scispace - formally typeset
J

Joseph A. Spernyak

Researcher at Roswell Park Cancer Institute

Publications -  66
Citations -  1863

Joseph A. Spernyak is an academic researcher from Roswell Park Cancer Institute. The author has contributed to research in topics: Medicine & Magnetic resonance imaging. The author has an hindex of 23, co-authored 60 publications receiving 1534 citations. Previous affiliations of Joseph A. Spernyak include University at Buffalo & State University of New York System.

Papers
More filters
Journal ArticleDOI

Genetically altered expression of spermidine/spermine N1-acetyltransferase affects fat metabolism in mice via acetyl-CoA.

TL;DR: A model is proposed whereby the expression status of spermidine/spermine N1-acetyltransferase alters body fat accumulation by metabolically modulating tissue acetyl- and malonyl-CoA levels, thereby influencing fatty acid biosynthesis and oxidation.
Journal ArticleDOI

Mild Elevation of Body Temperature Reduces Tumor Interstitial Fluid Pressure and Hypoxia and Enhances Efficacy of Radiotherapy in Murine Tumor Models

TL;DR: Induction of a thermoregulatory-mediated increase in tissue blood flow, induced by exposure of mice to mild environmental heat stress, could influence IFP and other vascular parameters within tumors, suggesting, for the first time, that environmental manipulation of normal vasomotor function is capable of achieving therapeutically beneficial changes in IFP in the tumor microenvironment.
Journal ArticleDOI

Peroxiredoxin 1 Controls Prostate Cancer Growth through Toll-Like Receptor 4 Dependent Regulation of Tumor Vasculature

TL;DR: It is shown that Prx1 is overexpressed in human CaP specimens and that it regulates prostate tumor growth through TLR4-dependent regulation of prostate tumor vasculature, providing a mechanistic link between inflammation andTLR4 in prostate carcinogenesis.
Journal ArticleDOI

Iron(II) PARACEST MRI Contrast Agents

TL;DR: CEST imaging using a MRI scanner shows that the CEST effect can be observed in solutions containing low millimolar concentrations of complex at neutral pH, 100 mM NaCl, 20 mM buffer at 25 °C or 37 °C.
Journal ArticleDOI

A Redox-Activated MRI Contrast Agent that Switches Between Paramagnetic and Diamagnetic States

TL;DR: The development of probes to map oxygen levels and corresponding redox status of tumor tissue may guide the development of tumor-selective drugs.